2019
DOI: 10.3390/cancers11060741
|View full text |Cite
|
Sign up to set email alerts
|

From a Philosophical Framework to a Valid Prognostic Staging System of the New “Comprehensive Assessment” for Transplantable Hepatocellular Carcinoma

Abstract: The comprehensive assessment of the transplantable tumor (TT) proposed and included in the last Italian consensus meeting still deserve validation. All consecutive patients with hepatocellular carcinoma (HCC) listed for liver transplant (LT) between January 2005 and December 2015 were post-hoc classified by the tumor/patient stage as assessed at the last re-staging-time (ReS-time) before LT as follow: high-risk-class (HRC) = stages TTDR, TTPR; intermediate-risk-class (IRC) = TT0NT, TTFR, TTUT; low-risk-class (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 17 publications
(23 citation statements)
references
References 36 publications
0
23
0
Order By: Relevance
“…In one recent paper, the 5-year overall survival was 70% and 60% in HCC patients who received live resection and ablation (p = 0.666) [27]. A same high survival and low recurrence was also observed in patients who received liver transplant [28]. Because of the non-significant difference of survival and small case numbers of liver transplant, we grouped, instead of separated, patients of these three difference curative therapies to compare with palliative/supportive therapies.…”
Section: Discussionmentioning
confidence: 83%
“…In one recent paper, the 5-year overall survival was 70% and 60% in HCC patients who received live resection and ablation (p = 0.666) [27]. A same high survival and low recurrence was also observed in patients who received liver transplant [28]. Because of the non-significant difference of survival and small case numbers of liver transplant, we grouped, instead of separated, patients of these three difference curative therapies to compare with palliative/supportive therapies.…”
Section: Discussionmentioning
confidence: 83%
“…Single HCC could benefit from both surgical resection (SR) or US-guided percutaneous ablation (PA) with similar oncological outcomes [ 8 , 9 , 10 ], although several studies advocate resection as the best treatment option [ 11 , 12 , 13 ]; notably, pathological analysis from surgical specimens could reveal the presence of unfavorable histological characteristics such as microvascular invasion or satellitosis, that may change future clinical decision making (i.e., favoring liver transplantation) [ 14 , 15 , 16 ]. Given this scenario, the aim of our study was to retrospectively evaluate the oncological impact of Li-RADS classification on single HCC treated by SR vs. PA.…”
Section: Introductionmentioning
confidence: 99%
“…A recent article from Di Sandro and colleagues [25] applies the comprehensive assessment of the transplantable tumor proposed by Mazzaferro [26] and included in the Italian Consensus-Based Approach to Organ Allocation in Liver Transplantation, concluding that high-risk patients, including partial response to bridging therapies or to downstaging, could benefit from a prioritization with a level of recurrence similar to intermediate-risk patients when transplanted quickly after re-staging. Even if they remain controversial (results of the article of Metha and Yao [27] propose a threshold to moderate the risk of selecting tumors with less favorable biology) and need wider validation, these results are interesting and could suggest, with our data, that the AFP model should be coupled to a prioritization system in order to improve the results of LT, including response to bridging therapies and downstaging.…”
Section: Discussionmentioning
confidence: 99%